Clinical Trials in San Antonio

Showing 12081-12100 of 12,572 trials

Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors

NCT00352131

RATIONALE: Monoclonal antibodies, such as maytansinoid DM4-conjugated humanized monoclonal antibody huC242, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This phase I trial is studying the side effects and best dose of maytansinoid DM4-conjugated humanized monoclonal antibody huC242 in treating patients with solid tumors that cannot be removed by surgery or have spread to other parts of the body.

Non-colorectal CancerPancreatic Cancer

ImmunoGen, Inc.50 participantsStarted Feb 2005

San Antonio, Texas, United States • San Antonio, Texas, United States

COMPLETED< 1 mile

Novel Rinse to Treat in Oral Candidiasis in Cancer Patients

NCT00612963

The purpose of the study is to evaluate the efficacy of Iocide oral rinse as a treatment for Oral Candidiasis in any patient including but not limited to patients receiving radiation therapy or who have previously received radiation therapy for head and neck cancer, or patients positive for HIV/AIDS or are transplant patients.

Candidiasis, OralThrushCandidiasis

Biomedical Development Corporation23 participantsStarted Apr 2007

Kansas City, Missouri, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

NCT00091598

The primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.

Pulmonary Hypertension

Gilead Sciences372 participantsStarted Jan 2004

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +43 more locations

Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors

Novel Rinse to Treat in Oral Candidiasis in Cancer Patients

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Find Trials by Condition in San Antonio

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Study of XL999 in Adults With Solid Tumors

Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Herpetic Eye Disease Study (HEDS) II

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Diabetes Control and Complications Trial (DCCT)

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

Study of XL999 in Patients With Previously Treated Ovarian Cancer